{
    "ticker": "CDXC",
    "name": "ChromaDex Corporation",
    "description": "ChromaDex Corporation is a global biosciences company dedicated to providing innovative solutions in the fields of nutrition, health, and wellness. Founded in 2006 and headquartered in Los Angeles, California, ChromaDex specializes in the research, development, and commercialization of natural ingredients derived from plants. The company is particularly known for its flagship product, TRU NIAGEN\u00ae, a patented form of nicotinamide riboside (NR), which is a compound that has been shown to boost levels of NAD+ (nicotinamide adenine dinucleotide) in the body, supporting cellular health and promoting healthy aging. ChromaDex\u2019s commitment to scientific research is reflected in its collaborations with various universities and research institutions, ensuring that its products are backed by robust scientific evidence. The company also focuses on sustainability and environmental responsibility, sourcing ingredients in a manner that supports ecological balance. Through its innovative products and dedication to research, ChromaDex aims to empower individuals to live healthier lives and improve their overall well-being.",
    "industry": [
        "Biosciences",
        "Nutraceuticals"
    ],
    "headquarters": "Los Angeles, California, USA",
    "founded": "2006",
    "website": "https://www.chromadex.com",
    "ceo": "Rob Fried",
    "social_media": {
        "twitter": "https://twitter.com/ChromaDex",
        "linkedin": "https://www.linkedin.com/company/chromadex/"
    },
    "investor_relations": "https://investors.chromadex.com",
    "key_executives": [
        {
            "name": "Rob Fried",
            "position": "CEO"
        },
        {
            "name": "Randy M. R. C. Kahn",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Nutritional Supplements",
            "products": [
                "TRU NIAGEN\u00ae"
            ]
        },
        {
            "category": "Ingredients",
            "products": [
                "Nicotinamide Riboside"
            ]
        }
    ],
    "seo": {
        "meta_title": "ChromaDex Corporation | Innovative Nutritional Solutions",
        "meta_description": "Explore ChromaDex Corporation, a leader in biosciences and nutritional products. Discover innovative solutions for health and wellness, including TRU NIAGEN\u00ae.",
        "keywords": [
            "ChromaDex",
            "Nutraceuticals",
            "TRU NIAGEN",
            "Nicotinamide Riboside",
            "Cellular Health",
            "Healthy Aging"
        ]
    },
    "faq": [
        {
            "question": "What is ChromaDex known for?",
            "answer": "ChromaDex is known for its innovative nutritional supplements, particularly TRU NIAGEN\u00ae, which supports cellular health."
        },
        {
            "question": "Who is the CEO of ChromaDex?",
            "answer": "Rob Fried is the CEO of ChromaDex Corporation."
        },
        {
            "question": "Where is ChromaDex headquartered?",
            "answer": "ChromaDex is headquartered in Los Angeles, California, USA."
        },
        {
            "question": "What are ChromaDex's main products?",
            "answer": "ChromaDex's main product is TRU NIAGEN\u00ae, a patented form of nicotinamide riboside."
        },
        {
            "question": "When was ChromaDex founded?",
            "answer": "ChromaDex was founded in 2006."
        }
    ],
    "competitors": [
        "AMRN",
        "NVCN",
        "VYGR"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}